Novel Chimeric Protein Vaccines Against Clostridium difficile Infection
Clostridium difficile infection (CDI) is the leading cause of world-wide nosocomial acquired diarrhea in adults. Active vaccination is generally accepted as a logical and cost-effective approach to prevent CDI. In this paper, we have generated two novel chimeric proteins; one designated Tcd169, comp...
Main Authors: | Shaohui Wang, Yuanguo Wang, Ying Cai, Ciaran P. Kelly, Xingmin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.02440/full |
Similar Items
-
Constructing conjugate vaccine against Salmonella Typhimurium using lipid-A free lipopolysaccharide
by: Tzu-Wei Chiu, et al.
Published: (2020-08-01) -
Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection
by: Shaohui Wang, et al.
Published: (2022-06-01) -
Core genome mediated potential vaccine targets prioritization against Clostridium difficile via reverse vaccinology - an immuno-informatics approach
by: Sara Aiman, et al.
Published: (2022-04-01) -
Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
by: Osamu Matsuoka, et al.
Published: (2018-02-01) -
A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections
by: Mackenzie Henderson, et al.
Published: (2017-09-01)